Reuters logo
BRIEF-Cellular Biomedicine adds second clinical site in the expansion of CAR-T Phase I clinical trial
May 15, 2017 / 11:00 AM / 7 months ago

BRIEF-Cellular Biomedicine adds second clinical site in the expansion of CAR-T Phase I clinical trial

May 15 (Reuters) - Cellular Biomedicine Group Inc

* Cellular Biomedicine Group (CBMG) announces the addition of a second clinical site in the expansion of its Chimeric Antigen Receptor T-cell (CAR-T) Phase I clinical trial for its CARD-1 trial in patients with non-hodgkin lymphoma (NHL)

* Cellular Biomedicine Group Inc - on track to share topline clinical data in Q4 of this year as it becomes available from CARD-1 trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below